JPS58179488A - Preparation of peroxidase - Google Patents

Preparation of peroxidase

Info

Publication number
JPS58179488A
JPS58179488A JP6369282A JP6369282A JPS58179488A JP S58179488 A JPS58179488 A JP S58179488A JP 6369282 A JP6369282 A JP 6369282A JP 6369282 A JP6369282 A JP 6369282A JP S58179488 A JPS58179488 A JP S58179488A
Authority
JP
Japan
Prior art keywords
peroxidase
bacillus
culture
solution
cytase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6369282A
Other languages
Japanese (ja)
Inventor
Kozaburo Okazaki
岡崎 弘三郎
Kazuhiro Ichikawa
和宏 市川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HANKYU KYOEI BUSSAN KK
UEDA KAGAKU KOGYO KK
Original Assignee
HANKYU KYOEI BUSSAN KK
UEDA KAGAKU KOGYO KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HANKYU KYOEI BUSSAN KK, UEDA KAGAKU KOGYO KK filed Critical HANKYU KYOEI BUSSAN KK
Priority to JP6369282A priority Critical patent/JPS58179488A/en
Publication of JPS58179488A publication Critical patent/JPS58179488A/en
Pending legal-status Critical Current

Links

Landscapes

  • Enzymes And Modification Thereof (AREA)

Abstract

PURPOSE:To prepare a peroxidase useful as an agent for clinical diagnosis and enzyme immunoassay, by culturing a microbial strain belonging to Bacillus genus and capable of producing peroxidase, and separating the accumulated enzyme. CONSTITUTION:A microbial strain belonging to Bacillus genus and capable of producing peroxidase, e.g. Bacillus cereus, Bacillus megaterium, etc. is cultured to produced and accumulate the peroxidase in the cultured product, and the peroxidase is separated therefrom. The cultivation can be carried out in a synthetic or natural medium containing nutrients and additives. The carbon source is, e.g. glucose, soluble starch, citric acid, etc. and the nitrogen source is, e.g. peptone, casein, meat extract, sodium nitrate, ammonium chloride, etc.

Description

【発明の詳細な説明】 本発明は微生物利用によるベルオ中シターゼの製造法、
更に詳しくはバチルス起源の新しいベル才十ジター!、
%に4−アミノアシチピリン(以下r4−AAJと略す
)−フェノール系、3−メチル−2−ベシリチアリリノ
シヒド5リシ(以下「MBTII」と略す)−ジメチル
アニリシ(以下「DMAJと略す)系、4−AA−DM
A系、及び4−AA−ジエチルアニリシ(以下rDEA
Jと略す)系を水素供与体として発色する新規なベルオ
士シターゼの製造法に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention provides a method for producing Veroin cytase using microorganisms,
For more details, check out the new Bell Saiju Jitter originating from Bacillus! ,
%, 4-aminoacytipyrine (hereinafter abbreviated as r4-AAJ)-phenolic, 3-methyl-2-besylytiarylinosyde 5-lysi (hereinafter abbreviated as "MBTII")-dimethylanilisi (hereinafter abbreviated as "DMAJ") ) system, 4-AA-DM
A series, and 4-AA-diethylanilisi (hereinafter referred to as rDEA)
This invention relates to a novel method for producing Beryl cytase that develops color using a hydrogen donor system (abbreviated as J).

ベルオ士シターゼは、過酸化水素の存在下で種々の化合
物を酸化する酵素であり、近年臨床診断試薬としてタル
〕−ス、総コレステロール、遊離型コレステ0−ル、リ
ン脂質および尿酸の定量に種々の1十ジターでと共に使
用されると共に、酵素免疫測定法にお叶る標識酵素とし
ても使用されている。従来これら試薬に配合されるベル
オ士シターゼとしては、専らその給源として大根、西洋
ワサビ等の植物が用いられているにすぎない、微生物起
源のべんオ+シターゼも一部知られているが、之等は細
菌及び糸状菌の生産するチトク〇−ムCベルオ士シダー
ゼやNADH−ベルオ+シターゼであり、植物起源にみ
られるような非特異的なベルオ+シターゼではなく、そ
の特異性の面で上記植物起源のベルオ+ジターぜに代替
できる臨床診断試薬用としては利用できない。又近年O
−ジアニシジンを水素供与体とするベルオ+シターゼが
大腸菌及びミロセシウム属に属する微生物から生産され
たがO−ジアニシジンは発癌性作用を有する丸め労働衛
生上その臨床的使用は回避される傾向にあり、やはシ上
記診断試薬としての使用には適していない。
Beryl oxidase is an enzyme that oxidizes various compounds in the presence of hydrogen peroxide, and has recently been used as a clinical diagnostic reagent in various ways to quantify talc, total cholesterol, free cholesterol, phospholipids, and uric acid. It is also used as a labeling enzyme for enzyme immunoassay. In the past, the sources of Beruoh+cytase used in these reagents were only plants such as radish and horseradish, and some Benoh+cytase derived from microorganisms was also known. is cytochrome C-berio+ sidase and NADH-beroo+ sidase produced by bacteria and filamentous fungi, and is not a non-specific beroo+ cytase found in plant origin, but is unique to the plants mentioned above in terms of its specificity. It cannot be used as a clinical diagnostic reagent that can replace the original Beluo+gitase. Also in recent years O
-O-dianisidine has been produced from Escherichia coli and microorganisms belonging to the genus Myrocesium, but O-dianisidine has carcinogenic effects.O-dianisidine tends to be avoided for industrial hygiene reasons, and its clinical use tends to be avoided. is not suitable for use as a diagnostic reagent.

本発明者らは、上記現状に鑑み臨床診断試薬および酵素
免疫測定法に供し得る性質を有するベルオ牛シターゼを
、増殖が速く、植物に比し大量生産が可能でしかも変異
その他の方法でその生産能力を飛躍的に向上させ得る可
能性のある微生物中に見い出し得るならば、産業上有益
であるとの見地から鋭意研究を行なつ九、その結果、臨
床診断薬として汎用されている4−AA−フェノール系
、4−AA−DMA系、4−AA−DEA系等の発色剤
によ〉呈色するベルオ中シターゼを生産する微生物とし
て、本発明者らは先K、アルタナリア属、コクリオボラ
ス属、ぺり中15リア属及びカーブラリア属に属する微
生物を見い出し、之郷黴生物利用によるベルオ中シター
ゼの製造方法を確立し、特許出願し九(特願昭55−1
7565号)。
In view of the above-mentioned current situation, the present inventors have developed Beruo bovine sitase, which has properties that can be used as a clinical diagnostic reagent and an enzyme immunoassay method, because it multiplies rapidly and can be produced in large quantities compared to plants. We are conducting intensive research from the viewpoint that it would be industrially beneficial if it could be found in microorganisms that have the potential to dramatically improve the ability of 4-AA.As a result, 4-AA, which is widely used as a clinical diagnostic agent - As microorganisms that produce Veroin cytase that develops color using color-forming agents such as phenol, 4-AA-DMA, and 4-AA-DEA, the present inventors have identified microorganisms that produce Veroin cytase, such as Alternaria, Alternaria, Cochliobolus, etc. He discovered microorganisms belonging to the genus Perichuria and Curbularia, and established a method for producing Verocytase by bioutilization of the fungus, and applied for a patent.
No. 7565).

本発明者らは引き続き広範囲に自然界より細菌を分離し
、分離菌を培養し、培養物につき過酸化水素の存在下に
おける4−AA−フェノール系等での発生の有無を検討
した結果、バチルス属に、所望のべ1才士シターゼ生産
菌が存在することを確堅し、この新しい知見に基づいて
本発明を完成するに至った。
The present inventors continued to isolate bacteria from the natural world over a wide range of areas, cultured the isolated bacteria, and investigated whether or not 4-AA-phenol-based substances occur in the culture in the presence of hydrogen peroxide. As a result, Bacillus spp. It was confirmed that the desired Bacterium cytase-producing bacteria existed, and the present invention was completed based on this new knowledge.

即ち本発明は、バチルス属に属しペル1十ジターを生産
能を有する微生物を栄養培地に培養し、培養物中にベル
才十シターゼを生成蓄積せしめ、これを採取することを
特徴とするベルオ牛シターゼの製造法に係る。
That is, the present invention provides a method for culturing a microorganism belonging to the genus Bacillus and having the ability to produce Pel-10-citase in a nutrient medium, producing and accumulating Pel-10-citase in the culture, and collecting the product. Relating to a method for producing cytase.

本発明においてバチルス属に属するベル才十シターゼ生
産能を有する微生物として1ま、例えばバチルス−Xづ
チリス(Bacillws 5LLbttLiz )、
バチルス・セレウス(B、 ctrtu、?) 、バチ
ルス・メガテリウム(B、 m−yatarium )
等のバチルス属に属する各種の微生物を用いることがで
きる。之等のうちで特に好適なもののひとつとしては、
本発明者らが新九に土壌中よシ分離し、[バチルス・セ
レウスUP (BttciLL討carauz UP 
) Jと命名した菌株を挙げることができる。該菌株の
菌学的性質を「医学細菌同定の手びき」第2版(近代出
版社)、「バチルスの第2次鑑別表」K準拠して調べた
結果は下記第1表に示す通りである。
In the present invention, examples of microorganisms belonging to the genus Bacillus having the ability to produce Bacillus cytase include, for example, Bacillus 5LLbttLiz,
Bacillus cereus (B, ctrtu, ?), Bacillus megaterium (B, m-yatarium)
Various microorganisms belonging to the genus Bacillus can be used. Among these, one of the most suitable is:
The present inventors isolated Bacillus cereus in the soil and found that it was
) The strain named J. The mycological properties of the strain were investigated in accordance with the ``Medical Bacterial Identification Manual'' 2nd Edition (Kinda Publishing) and the ``Second Differential Table of Bacillus'' K, and the results are shown in Table 1 below. be.

第  1  表 上記第1表より本菌株はバチルス・セレウスと同定され
る。該菌株は工業技術院微生物工業技術研究所に、徴工
研菌寄第6503号(FERMSPA−6503)とし
て受託され友。
Table 1 From Table 1 above, this bacterial strain is identified as Bacillus cereus. The strain was entrusted to the National Institute of Microbiology, Agency of Industrial Science and Technology as FERMSPA-6503.

ま九本発明に好適に用いられる他の微生物としては、具
体的には例えばバチルス・セレウスIFO3132、バ
チルス・セレウスIP03836、バチルス・セレウス
IF013690、バチルス・メガテリウムIFO39
70、バチルス・ズブチリスIP03936等を例示で
きる。
Other microorganisms suitably used in the present invention include, for example, Bacillus cereus IFO3132, Bacillus cereus IP03836, Bacillus cereus IF013690, and Bacillus megaterium IFO39.
70 and Bacillus subtilis IP03936.

本発明は上記各種の菌株又はそれらの変異株を利用して
以下の通り実施される。即ちまず上記微生物を栄養培地
に培養する。培養は通常の栄養物及び添加物を含有する
合成培地又は天然培地で行ない得る。訳素源としてはグ
ルコース、マルトース、サッカローズ、ガラクトース、
フラクトース、キシロース、マンノーズ、ラフィノース
、可溶性澱粉、液化澱粉、糖蜜、グリセ0−ル、ソルビ
トール、クエシ酸、コへり酸等の一般的に使用されるも
のがいずれも使用できる。窒素源としてはべづトシ、酵
母工十ス、脱脂大豆、ガゼイシ、肉工十ス、カザミノ酸
、コーシスチープリカー等の天然窒素源の他更に硝酸ナ
トリウム、硝酸アンモニウム、硫酸アンモニウム、塩化
アンモニウム等の無機窒素が使用できる。この他必要に
応じリン酸塩、硫酸マグネシウム、硫酸鉄、硫酸鋼、硫
酸亜鉛、塩化鉄、塩化]バルト、塩化マシガシ等の無機
塩およびピタ三シ等も微量栄養源として使用できる。こ
れらの培地成分は培養すべき各微生物の生育を阻害しな
い濃度で用いられ、これは夫々の微生物により若干相違
するが通常の振盪培養又は通気攪拌培養にあっては一般
的に炭素源は0.1〜10重量嘩、好ましくは0.5〜
7重量%、窒素源は0.01〜8重量%、好ましくは0
.1〜5重量%の濃度とするのがよい。また培地のpH
は4〜11、好ましくは5〜10とし、培iI温度は2
0〜45℃、好ましくは25〜38℃とするのがよく、
培養は通常約2〜10日間で行なわれる。
The present invention is carried out as follows using the above-mentioned various strains or mutant strains thereof. That is, first, the above-mentioned microorganism is cultured in a nutrient medium. Cultivation can be carried out in synthetic or natural media containing conventional nutrients and additives. Glucose, maltose, saccharose, galactose,
Any commonly used substances such as fructose, xylose, mannose, raffinose, soluble starch, liquefied starch, molasses, glycerol, sorbitol, quesic acid, cohelic acid, etc. can be used. Nitrogen sources include natural nitrogen sources such as Bezutoshi, Yeast Kojusu, defatted soybeans, Gazeishi, Meat Kojusu, Casamino acids, and Kosi Cheap Liquor, as well as inorganic sources such as sodium nitrate, ammonium nitrate, ammonium sulfate, and ammonium chloride. Nitrogen can be used. In addition, inorganic salts such as phosphates, magnesium sulfate, iron sulfate, steel sulfate, zinc sulfate, iron chloride, baltic acid chloride, and pita chloride can also be used as trace nutrient sources, if necessary. These medium components are used at concentrations that do not inhibit the growth of each microorganism to be cultured, and although this varies slightly depending on each microorganism, in general shaking culture or aerated agitation culture, the carbon source is generally 0. 1-10% by weight, preferably 0.5-10% by weight
7% by weight, nitrogen source 0.01-8% by weight, preferably 0
.. The concentration is preferably 1 to 5% by weight. Also, the pH of the medium
is 4 to 11, preferably 5 to 10, and the culture iI temperature is 2.
The temperature is preferably 0 to 45°C, preferably 25 to 38°C,
Cultivation is usually carried out for about 2 to 10 days.

上記培養によシ培養物中に所望のベルオ中シターゼが産
生蓄積される。ここで培養物とは生産され九菌体および
培養上澄液もしくは培養p液を意味する。これら培養物
からベル才十シ〈−ゼを採取する方法は、常法に従えば
よく、例えば培養終了後の培養液より遠心分離および濾
過などにより菌体および不溶物を除去することにより粗
酵素液を得る。ま九菌体中に含まれるベルオ+シターゼ
は摩砕又は超音波尋の手段によシ菌体を破壊彼酵素を抽
出することによっても粗酵素液として収得できる。更に
菌体を含む培養液をそのtま超音波処理するととKよシ
菌体を破壊し九のち不溶物を除去することによっても粗
酵素液を得ることが可能である。ま友得られ友粗酵素液
の精製操作本通常の方法に従えばよく、例えば硫酸アシ
七ニウム分画沈殿法、透析、吸着剤による分別法、有機
溶媒分別法、等電点沈殿法、各種イオン交換体によるカ
ラムク0マドクラフイー及びアフィニティークロマトタ
ラフィーなどを単独に或は組合せて利用できる。かくし
て精製されたペルオ+シターゼを収得する。
By the above-mentioned culture, the desired Verocytase is produced and accumulated in the culture. The term "culture" as used herein means the nine microbial cells produced and the culture supernatant or culture p solution. The method for collecting Bell Saijucyse from these cultures may be in accordance with a conventional method, for example, by removing the bacterial cells and insoluble matter from the culture solution after the completion of culture by centrifugation and filtration. Get the liquid. The cytase contained in the bacterial cells can also be obtained as a crude enzyme solution by destroying the bacterial cells by grinding or ultrasonication and extracting the enzyme. Furthermore, it is also possible to obtain a crude enzyme solution by subjecting a culture solution containing microbial cells to ultrasonic treatment for a while to destroy the microbial cells and then removing insoluble matter. Purification of crude enzyme solution may be carried out by following conventional methods, such as fractional precipitation method of aci7nium sulfate, dialysis, fractionation method using adsorbent, organic solvent fractionation method, isoelectric focusing method, etc. Column chromatography using an ion exchanger, affinity chromatography, and the like can be used alone or in combination. Purified perio+cytase is thus obtained.

本発明におけるベル才十シターゼ活性の測定は、水素供
与体として臨床診断試薬に用いられる今−A、4−フェ
ノール系を使用して行った。すなわちo、+yすvH1
l衝液(PH7,0)IdKo、08%4−A A溶液
Q、5wl、 0.4%フェノール溶液0.5ゴノ之び
0.15チ過酸化水素溶液111!を加え30℃に予熱
後、これに酵素液1dを加えて15分間反応させ直ちに
510九属の波長でその吸光度を測定する。別に対照と
して過酸化水素溶液の代わりに水を11加え同様の操作
によって吸光度を測定次に本発明で得られたベル才十シ
づ−ゼの酵素化学的性質を示す。
In the present invention, the activity of Bell's Cytase was measured using Ima-A,4-phenol, which is used in clinical diagnostic reagents, as a hydrogen donor. That is, o, +ysvH1
l buffer solution (PH7,0) IdKo, 08% 4-A A solution Q, 5 wl, 0.4% phenol solution 0.5 ml, 0.15 ml hydrogen peroxide solution 111! After preheating to 30° C., add 1 d of enzyme solution and react for 15 minutes, and immediately measure the absorbance at a wavelength of 5109. Separately, as a control, water was added in place of the hydrogen peroxide solution and the absorbance was measured by the same procedure.Next, the enzymatic chemical properties of the Bell Saiju Cydase obtained in the present invention will be shown.

(1)作用特異性; 本酵素は過酸化水素に極めて特異的に作用し、過酸化水
素の存在下で種々の水素供与体として機能する化合物の
酸化を触媒する。その作用機構は次式に示す通シである
(1) Specificity of action: This enzyme acts very specifically on hydrogen peroxide, and catalyzes the oxidation of various compounds that function as hydrogen donors in the presence of hydrogen peroxide. Its mechanism of action is as shown in the following equation.

ベルオ+シターゼ H2O2+AH22H20+A 〔但し式中J2は水素供与体を、またAは酸化され九水
素供与体を示す、〕 (2)  至適PH; p H4,5〜10の範囲につきプリトシー〇ビシソシ
の広域緩衝液(0,04J/リシ酸−0,04M酢酸−
0,04M硼酸と0.2M苛性ソータの混合液)を使用
して、活性測定と同様の配合比率で検討した。その結果
を第1図に示す。
Vero + Cytase H2O2 + AH22H20 + A [However, in the formula, J2 represents a hydrogen donor, and A represents an oxidized 9-hydrogen donor.] (2) Optimum pH; pH range of 4.5 to 10, wide range buffering liquid (0.04J/ricic acid-0.04M acetic acid-
A mixed solution of 0.04M boric acid and 0.2M caustic sorter) was used at the same mixing ratio as in the activity measurement. The results are shown in FIG.

(3)至適作用温度; 30〜70CKおける酵素活性を測定し九結果を第2図
に示す。
(3) Optimum action temperature: Enzyme activity was measured at 30 to 70 CK and the results are shown in FIG.

(4) PH安定性: 酵素液1ILtを、pH4,0〜10のづリドシー0ピ
シソシ緩衝液411LIK加え30℃に17時間放置し
た。酵素活性測定時K O,4Mリシ酸緩衝液5Il/
を加え、p H7,0とし、残存酵素力価を測定した結
果を第3図に示す。
(4) PH stability: Enzyme solution 1ILt was added to Zuridocyoshi buffer solution 411LIK with a pH of 4.0 to 10 and left at 30°C for 17 hours. When measuring enzyme activity, KO, 4M lysic acid buffer 5Il/
was added to adjust the pH to 7.0, and the residual enzyme titer was measured. The results are shown in FIG.

(6)温度安定性; 0.02Mリシ酸緩衝液(PH8,0)5mに酵素5 
mlを加えて調製した酵素液を、20〜80℃の温度に
30分間保ち処理後直ちに氷水で10分間冷却した後残
存酵素活性を測定した。その結果を第4図に示す。
(6) Temperature stability: 5 m of 0.02 M lysic acid buffer (PH8,0)
The enzyme solution prepared by adding ml of the enzyme solution was kept at a temperature of 20 to 80°C for 30 minutes, and immediately after the treatment, it was cooled with ice water for 10 minutes, and then the residual enzyme activity was measured. The results are shown in FIG.

(6)  力価の測定法; 前述した通りである。(6) Measurement method of titer; As mentioned above.

(7)各種発色剤による発色度の比較 臨床診断試薬用として使用されている発色剤のうち下記
4種類の薬剤について検討した。即ち発色剤以外の条件
を統一し、4−AA−フェノール系は、前記の力価測定
と同一条件で行なつ九。4−AA−DMA系〔衛生検査
25.(5) 、 312 )の場合は、4−AA−D
MA混液C0,036%4AA及び0.05%DMA)
2dの配合で560路属の吸光度を測定し友。8−ハイ
ド0+ノリン(8fQ)−F−Fニシジ、、’ (PA
 ”)系〔Ckg罵、Pルαrm、 BuLL、 。
(7) Comparison of the degree of color development by various color formers Among the color formers used for clinical diagnostic reagents, the following four types of chemicals were investigated. That is, the conditions other than the color former were unified, and 4-AA-phenol was measured under the same conditions as the titer measurement described above. 4-AA-DMA system [Hygiene inspection 25. (5), 312), 4-AA-D
MA mixture C0,036% 4AA and 0.05% DMA)
Measure the absorbance of 560 genus with 2d formulation. 8-Hyde 0 + Norin (8fQ) -F-F Nishiji,,' (PA
”) system [Ckg abuse, Ple αrm, BuLL, .

27.568,1979)の場合は、0.72 % 8
−ハイド0牛ノリシ溶液Q、5m、0.56チP−アニ
シジシ溶液0.51の配合で600%富の吸光度を測定
し友、MBTH−DMA系〔CLiWieaL Che
w、 。
27.568, 1979), 0.72% 8
-Measure the absorbance of 600% rich with Hyde 0 Beef Norishi solution Q, 5m, 0.56th
lol.

18.943.1972)の場合は、MBTH−DMA
混液C0,04%METH及び0.061DMA)Im
の配合で590F&llLの吸光度を測定した。測定結
果を下記第2表に示す。
18.943.1972), MBTH-DMA
Mixture C0.04% METH and 0.061DMA) Im
The absorbance of 590F&llL was measured with the following formulation. The measurement results are shown in Table 2 below.

第  2  表 次に本発明実施例を示す。Table 2 Next, examples of the present invention will be shown.

実施例 ! 可溶性澱粉41.べづトン2%及びコーンステイつりカ
ー0.31を含有する液体培養液CpH7,0)を50
01I7!容坂ロ氏コルベシに5011j入れ、120
℃で30分間殺菌後、これにバチルス・セレウスUPを
予め上記と同組成の液体培養液で19時間振盪培養して
得九液を中種としてQ、5*1植菌し、て、30℃で4
日間振盪培養し友。培養終了後+ 00 OrPMで1
5分間遠心分離して粗酵素液(p#8.8)を得た。こ
の粗酵素液のベル才牛シジーゼ活性は0.54単位であ
った。
Example ! Soluble starch41. 50% liquid culture medium CpH 7.0) containing 2% Bedstone and 0.31 cornstay suspension.
01I7! Mr. Yosakaro put 5011j in Kolbeshi, 120
After sterilizing at ℃ for 30 minutes, Bacillus cereus UP was cultured with shaking for 19 hours in a liquid culture solution with the same composition as above, and Q, 5 * 1 was inoculated using the 9 liquid as medium seed, and then incubated at 30℃. So 4
Culture with shaking for days. After completion of culture + 1 at 00 OrPM
A crude enzyme solution (p#8.8) was obtained by centrifugation for 5 minutes. This crude enzyme solution had a Bell's schizase activity of 0.54 units.

実施例 2 グリコース!優、可溶性澱粉l−、ベプトシ4チ、]−
システィづリカー〇、1嘔、0.目0ん酸緩衝液CpH
7−0)、硝酸アシ七ニウム0.0411並びに硼酸、
塩化鋼、塩化カルシウム及び塩化マンガシ各0.02M
を含有する組成の液体培養液(7)H7,0)IOtを
301容ジヤーフアメシターに仕込み、120℃で40
分間殺菌後、これにバチルス・セレウスUPを予め同組
成培地で19時間振盪培養して得た培養液5017を植
菌し、30℃下、通気量0.25シシ罵の条件下に通気
攪拌培養した。培養24時間後の培養液の一部を採取し
、+ooorpmで15分間遠心分離して菌体を分離後
、生理食塩水で洗浄し、湿潤状の菌体5tを得た。これ
に海砂0.5tとO,0Iffiりん酸緩衝液の少量を
加え、乳鉢で磨破し、同緩衝液を加えて全容を100−
とじ死後、s o o o rpmで15分間遠心分離
して、上溌液として粗酵素液を得た。
Example 2 Glyose! Excellent, soluble starch l-, beptoshi4chi, ]-
Sisti liquor〇, 1 vomit, 0. Acid buffer CpH
7-0), aci7nium nitrate 0.0411 and boric acid,
Chlorinated steel, calcium chloride and mangaka chloride 0.02M each
A liquid culture solution containing (7)H7,0)IOt was charged into a 301 volume jar, and heated at 120℃ for 40 hours.
After sterilization for 1 minute, culture solution 5017 obtained by culturing Bacillus cereus UP in the same composition medium for 19 hours with shaking was inoculated thereto, and cultured with aeration at 30°C with aeration rate of 0.25 sq. did. After 24 hours of culture, a portion of the culture solution was collected and centrifuged at +ooorpm for 15 minutes to separate the bacterial cells, which were then washed with physiological saline to obtain 5 tons of wet bacterial cells. Add 0.5t of sea sand and a small amount of 0.0Iffi phosphate buffer to this, grind it in a mortar, add the same buffer, and reduce the total volume to 100%.
After binding, the mixture was centrifuged at SOOO rpm for 15 minutes to obtain a crude enzyme solution as a supernatant.

この粗酵素液のベルオ士シターゼ活性は0.1単位であ
った。
This crude enzyme solution had a citase activity of 0.1 unit.

−また上記において培養を更に継続させ、培養72時間
後に得られ九培養液を、同様に遠心分離するか又はりん
酸カルシウムゲル及び戸遇助剤の存在下に吸引p過して
菌体を除去し、粗酵素液(12単位/d)を得た。
- In addition, the culture was further continued in the above manner, and the culture solution obtained after 72 hours of culture was similarly centrifuged or filtered by suction in the presence of calcium phosphate gel and a household aid to remove bacterial cells. A crude enzyme solution (12 units/d) was obtained.

得られた粗酵素液に硫酸アシ上20665重量優を加え
生ずる塩析物をp過助剤の添加後吸引ν過によ塾捕集し
、0.02Ml−リス−塩酸緩衝液(PH8,0)50
0+jに溶解し、七〇ファンチューづを用いて同緩衝液
に対して透析し、(jil!アシtニウムを除去した。
Addition of 20,665% by weight of sulfuric acid to the obtained crude enzyme solution resulted in a salting out product, which was collected by suction filtration after addition of a p-superior. )50
0+j and dialyzed against the same buffer using 70 Fan Chews to remove acitium.

得られた透析内液を予め0.02J/)リス−塩酸緩衝
液(pH7,5)で平衡化し六「タイマドックスづり−
B」(アミコシ・ファー・イースト・リミテッド製)の
ガラ乙に通じ、ベルオ+シターゼを吸着させ、同緩衝液
で洗浄した後、30チエチレシクリコール溶液(pH7
,5に調整)で溶出し、溶出液をtOファンチューづを
用いて純水に対して透析し、次いでコ0ジオシ膜で濃縮
し、濃縮液を凍結乾燥してベルオ牛シターゼの粉末を得
た。このものの培養ν液力・もの活性収率は48チであ
り、比活性(単位10D28゜)は19.06であった
The obtained dialysate solution was equilibrated in advance with 0.02 J/) Lis-HCl buffer (pH 7.5) and placed in a six-hour timer dock.
B" (manufactured by Amikosi Far East Ltd.) to adsorb Vero + Cytase, wash with the same buffer, and add 30% thiethylene cyclolicol solution (pH 7).
, adjusted to 5), the eluate was dialyzed against pure water using a t0 fan tube, and then concentrated using a tO diosi membrane, and the concentrated solution was lyophilized to obtain a powder of Beruo bovine citase. Ta. The culture v/mo activity yield of this product was 48 cm, and the specific activity (unit: 10D28°) was 19.06.

実施例 3 可溶性澱粉41脱脂大豆粉3チ及びコーシステイづリカ
ー〇、3嘩を含有する組成の液体培養液(PH7,0)
を、500m11容坂口氏コルベンに50wLl入れ、
120℃で30分間殺菌後、これにバチルス・セレウス
IFO3132(BαCilluC11lusc Fr
ankLand b FrankLand I F 0
3132 )のl白金耳を植菌し、30℃で4日間培養
後、+ o o o o rpmで15分間遠心分離し
粗酵素液を得た。この粗酵素液のベルオ+シターゼ活性
は0.094単位であった。
Example 3 Liquid culture solution with a composition containing 41 parts of soluble starch, 3 parts of defatted soybean flour, and 3 parts of Kosi Stay Liquor (PH7.0)
Put 50wLl into 500m11 Mr. Sakaguchi Colben,
After sterilizing at 120°C for 30 minutes, Bacillus cereus IFO3132 (BαCilluC11lusc Fr
ankLand b FrankLand I F 0
3132) was inoculated and cultured at 30°C for 4 days, followed by centrifugation at + o o o o o rpm for 15 minutes to obtain a crude enzyme solution. The Vero+cytase activity of this crude enzyme solution was 0.094 units.

実施例4及び5 下記微生物を用いて上記実施例3と同一操作を繰り返し
友。
Examples 4 and 5 The same operations as in Example 3 above were repeated using the following microorganisms.

実施例今 バチルス・セレウスIPOf3690(B、
cgrt&&z  FrankLancL  &  F
rankland  zuhzp。
Example: Bacillus cereus IPOf3690 (B,
cgrt&&z FrankLancL&F
rankland zuhzp.

f ttortpcgnz Lα;bαCルIFO13
690)実MNfl15  バチルス・セレウスIFO
3836)(B、 etrtuz Frathklan
ct & FratshLatsd zwbzp。
f ttortpcgnz Lα;bαC le IFO13
690) Real MNfl15 Bacillus cereus IFO
3836) (B, etrtuz Frathklan
ct & FratshLatsd zwbzp.

rxycoidmz Sm1th at al IFO
3836)得られた粗酵素液のベルオ+シターゼ活性は
、実施例4で0.07単位及び実施例5で0.105単
位であった。
rxycoidmz Sm1th at al IFO
3836) The Vero+cytase activity of the obtained crude enzyme solution was 0.07 units in Example 4 and 0.105 units in Example 5.

実施例 6 バチルス・メ刀チリウムIFO3970CB。Example 6 Bacillus methylium IFO3970CB.

ngtqattriwr′ILdt Bary I F
 03970 )を用い、実施例3と同様にして粗酵素
液を得た。得られた粗酵素液のベルオ+シターゼ活性は
0.015単位であった。
ngtqattriwr'ILdt Bary I F
03970) to obtain a crude enzyme solution in the same manner as in Example 3. The Vero+cytase activity of the obtained crude enzyme solution was 0.015 units.

実施例 7 バチルス・ズブチリスry03936(B。Example 7 Bacillus subtilis ry03936 (B.

zuhtilLiz (Ehrgnbgrg ) Co
五旙、IFO3936)を用い、実施例3と同様にして
粗酵素液を得九。
zuhtilLiz (Ehrgnbgrg) Co
A crude enzyme solution was obtained in the same manner as in Example 3 using IFO3936).

このもののベルオ士シターゼ活性は0.021単位であ
った。
The activity of this product was 0.021 units.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は本発明ベル才十シターゼの至適pHを示す図、
第2図は本発明ベルオ士シターゼの至適温度を示す図並
びに第3図及び第4図は本発明ベル才十シターゼのpH
安定性及び熱安定性を示す図である。 (以 上) 第1図 12図 作用51JtG” 第ろ図 第4 図 九玉里娼皮C゛ 手 続補 正 書(峠) 昭和57年6型i4日 持J′)庁長官殿 1、事ぐ1の表示 昭和57年脅 許 願第6’$692  号パ10− 
ペシオ中シ」−ゼの製造法 3、補正をする者 事件との関係  特許出願人 上田化参工癩棒弐食社 (ほか14) 4、代理人 大阪市東区平野町2の10平和ビル内電l占06−.2
03−0941(ずt)8、補正の内容 別紙添附の通り 補  正  の  内  春 (1)  明細書中の記載を下記正誤表の通り訂正する
。 (以 上)
FIG. 1 is a diagram showing the optimum pH of the present invention Bell-saijucytase;
FIG. 2 is a diagram showing the optimum temperature of the present invention Bell's Cytase, and FIGS. 3 and 4 show the pH of the present invention's Bell's Cytase.
FIG. 3 is a diagram showing stability and thermal stability. (Above) Figure 1 Figure 12 Action 51JtG'' Figure 4 Figure 4 Kudamari Prostitute C゛Procedural Amendment (Toge) 1981 Type 6 i4 Day J') Director-General of the Agency 1. Display of 1 1981 Permanent Application No. 6'$692 Part 10-
Manufacturing method for Pesio Nakashi'-ze 3. Relationship with the case of the person making the amendment Patent applicant Ueda Kasanko Lebo Nishokusha (and 14 others) 4. Agent in Heiwa Building, 2-10 Hirano-cho, Higashi-ku, Osaka Electric fortune telling 06-. 2
03-0941 (Zt) 8, Contents of the Amendment As shown in the attached sheet, Spring (1) The statement in the specification is corrected as shown in the errata below. (that's all)

Claims (1)

【特許請求の範囲】[Claims] ■ バチルス属に属しベルオ中シターゼ生産能を有する
微生物を栄養培地に培養し、培養物中にペルオ+シター
ゼを生成蓄積せしめ、これを採取することを特徴とする
ベルオ十シターゼの製造法。
■ A method for producing pero+sitase, which comprises culturing a microorganism belonging to the genus Bacillus and having the ability to produce pero+sitase in a nutrient medium, producing and accumulating pero+sitase in the culture, and collecting the same.
JP6369282A 1982-04-15 1982-04-15 Preparation of peroxidase Pending JPS58179488A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP6369282A JPS58179488A (en) 1982-04-15 1982-04-15 Preparation of peroxidase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6369282A JPS58179488A (en) 1982-04-15 1982-04-15 Preparation of peroxidase

Publications (1)

Publication Number Publication Date
JPS58179488A true JPS58179488A (en) 1983-10-20

Family

ID=13236675

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6369282A Pending JPS58179488A (en) 1982-04-15 1982-04-15 Preparation of peroxidase

Country Status (1)

Country Link
JP (1) JPS58179488A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0171074A2 (en) * 1984-08-07 1986-02-12 Suntory Limited A peroxidase and a process of its preparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0171074A2 (en) * 1984-08-07 1986-02-12 Suntory Limited A peroxidase and a process of its preparation

Similar Documents

Publication Publication Date Title
JPS6033474B2 (en) Novel hyaluronidase BMP-8231 and its production method
JPS61104784A (en) Production of peroxidase
US4283494A (en) Microbial lipase, process for its preparation and microbiologically pure culture therefor
JPH03236766A (en) Ascorbate oxidase and use thereof
US4064010A (en) Purification of uricase
JPS585035B2 (en) Method for producing peroxidase
JPS58179488A (en) Preparation of peroxidase
JPH044874A (en) Fructosylamino acid hydrolase, production and utilization thereof
JP2882652B2 (en) Alkaline protease and its producing microorganism
JP2544094B2 (en) Method for producing alkaline cellulase
JPS59179075A (en) Preparation of peroxidase
JPS6362195B2 (en)
JPS61115489A (en) Preparation of bacteriolytic enzyme
JPS58152481A (en) Novel phospholipase d-p and preparation thereof
JP3152855B2 (en) Novel sorbitol dehydrogenase, method for producing the same, reagent and method for quantifying sorbitol using the enzyme
JPS6031473B2 (en) Method for producing polyamine oxidases using microorganisms
JP3030916B2 (en) Method for producing β-glucooligosaccharide
JP2799621B2 (en) Method for producing phospholipase D
JPH0239237B2 (en) SHUSANOKISHIDAAZENOSEIZOHO
JPS6228678B2 (en)
FR2517698A1 (en) METHOD FOR DETERMINING ETHANOLAMINE
JPS58198291A (en) Beta-galactosidase and its production
JPH09247A (en) D-lactate dehydrogenase and its production
GB1571877A (en) Microbial lipase and its preparation
JPH07155179A (en) Production of ascorbic acid oxidase